Edition:
United Kingdom

Medivir AB (MVIRb.ST)

MVIRb.ST on Stockholm Stock Exchange

36.30SEK
1:55pm BST
Change (% chg)

0.00kr (+0.00%)
Prev Close
36.30kr
Open
36.50kr
Day's High
36.70kr
Day's Low
36.10kr
Volume
42,939
Avg. Vol
62,963
52-wk High
72.75kr
52-wk Low
32.10kr

Chart for

About

Medivir AB is a Sweden-based pharmaceutical company engaged in the research, development and sale of drugs against widespread diseases, with protease and polymerase as its target enzymes. The Company’s research focuses on developing small molecule pharmaceuticals, primarily against infectious diseases caused by viruses. The... (more)

Overall

Beta: 1.15
Market Cap(Mil.): kr1,394.06
Shares Outstanding(Mil.): 19.84
Dividend: --
Yield (%): --

Financials

  MVIRb.ST Industry Sector
P/E (TTM): -- 85.83 33.69
EPS (TTM): -14.03 -- --
ROI: -33.02 0.58 14.30
ROE: -34.12 1.62 16.03

BRIEF-Medivir Q1 operating loss narrows

* MEDIVIR Q1 NET TURNOVER TOTALED SEK 4.5 MILLION (17.8 M)OF WHICH SEK 4.5 MILLION (13.7 M) COMPRISED THE FIRST QUARTER’S ROYALTIES

27 Apr 2018

Earnings vs. Estimates